Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children and young people
Closed for comments This consultation ended on at Request commenting lead permission
3 Committee considerations
The evidence
3.1 NICE did a rapid review of the published literature on the efficacy and safety of this procedure. This comprised a comprehensive literature search and detailed review of the evidence from 4 sources, which was discussed by the committee. The evidence included 2 retrospective case series, 1 retrospective cohort study and 1 prospective cohort study. It is presented in the summary of key evidence section in the interventional procedures overview. The committee also considered data available from the US Food and Drug Administration website. Other relevant literature is in the appendix of the overview.
3.2 The professional experts and the committee considered the key efficacy outcomes to be: correction of the scoliosis, maintenance of spinal mobility and quality of life.
3.3 The professional experts and the committee considered the key safety outcomes to be: osteolysis, pain, infection, metallosis and damage to adjacent structures.
Committee comments
3.4 The committee noted that this device is intended to be left in-place for life.
3.5 The committee was informed that there is more than 1 version of the device and that the technology is evolving.
Tom Clutton-Brock
Chair, interventional procedures advisory committee
January 2023
ISBN:
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions